Losing weight in the new year won't take the same shape as it did in the past. Why it matters: The emergence of ...
It hasn’t been a smooth year for the two pharma giants, but events in the fourth quarter widened the gap between them.
In 2024, new medicines changed how we think about healthy weight loss—but psychological factors remain just as important as ...
Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...
In Michigan, the state’s largest insurer has tightened restrictions around medications like Wegovy. Patients are panicking.
Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...
Experts are urging anyone looking to shed a few pounds in the New Year to think twice before buying dangerous weight-loss ...
The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...
Billionaire entrepreneur and top adviser to President-elect Donald Trump, Elon Musk, touted that he has reaped the benefits of Ozempic after fellow top Trump adviser, Robert F. Kennedy Jr., suggested ...
GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...
The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...
Up to a third of the weight lost while taking weight loss jabs such as Wegovy and Mounjaro includes muscle and bone mass.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback